BIFIDO Co., Ltd. (KOSDAQ:238200)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,845.00
-30.00 (-1.04%)
At close: Mar 6, 2026
Market Cap23.27B -8.2%
Revenue (ttm)18.65B +40.9%
Net Income-246.68M
EPS-30.17
Shares Out8.18M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume24,584
Average Volume28,102
Open2,875.00
Previous Close2,875.00
Day's Range2,695.00 - 2,875.00
52-Week Range2,460.00 - 4,390.00
Beta1.13
RSI41.80
Earnings DateMar 13, 2026

About BIFIDO

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1999
Employees 83
Stock Exchange KOSDAQ
Ticker Symbol 238200
Full Company Profile

Financial Performance

Financial Statements